Hepatocellular Carcinoma: Molecular Pathways and New Therapeutic Targets
作者： Lewis R Roberts , Gregory J Gores
关键词: Chronic liver disease 、 Receptor tyrosine kinase 、 Cancer research 、 Targeted therapy 、 Biology 、 Cancer 、 PI3K/AKT/mTOR pathway 、 Hepatocellular carcinoma 、 Wnt signaling pathway 、 Protein kinase B
摘要: … Up until now, most therapeutic agents have been developed … to the development of novel therapeutics targeted against the … be developed to yield a new class of anticancer therapeutics. …
elsevier.com
thieme-connect.de参考文章(86)
A. V. Jones, N. C. P. Cross, Oncogenic derivatives of platelet-derived growth factor receptors. Cellular and Molecular Life Sciences. ,vol. 61, pp. 2912- 2923 ,(2004) , 10.1007/S00018-004-4272-Z
Yehuda Z. Patt, Manal M. Hassan, Richard D. Lozano, Ajay K. Nooka, Isaac I. Schnirer, Jerome B. Zeldis, James L. Abbruzzese, Thomas D. Brown, Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial. Cancer. ,vol. 103, pp. 749- 755 ,(2005) , 10.1002/CNCR.20821
Jeung-Whan Han, Hoi Young Lee, Seung Hee Park, Dong-Wan Seo, Sungyoul Hong, Hyoung-Keun Kwon, Yin-Won Lee, Hyang-Woo Lee, So Young Wang, Gyu-Un Bae, Seong Hoon Ahn, Apicidin, a Histone Deacetylase Inhibitor, Inhibits Proliferation of Tumor Cells via Induction of p21WAF1/Cip1 and Gelsolin Cancer Research. ,vol. 60, pp. 6068- 6074 ,(2000)
Magnus Von Knebel Doeberitz, Susanne Dihlmann, Simone Klein, Reduction of β-Catenin/T-Cell Transcription Factor Signaling by Aspirin and Indomethacin Is Caused by an Increased Stabilization of Phosphorylated β-Catenin Molecular Cancer Therapeutics. ,vol. 2, pp. 509- 516 ,(2003)
Yoo Hong Min, Ho Young Maeng, June Won Cheong, Ju In Eom, Hoi Kyung Jeung, Ji Yeon Kim, Seung Tae Lee, So Young Chong, Induction of Apoptosis by Apicidin, a Histone Deacetylase Inhibitor, via the Activation of Mitochondria-Dependent Caspase Cascades in Human Bcr-Abl-Positive Leukemia Cells Clinical Cancer Research. ,vol. 9, pp. 5018- 5027 ,(2003)
Masaru Moriyama, Yujin Hoshida, Motoyuki Otsuka, ShinIchiro Nishimura, Naoya Kato, Tadashi Goto, Hiroyoshi Taniguchi, Yasushi Shiratori, Naohiko Seki, Masao Omata, None, Relevance network between chemosensitivity and transcriptome in human hepatoma cells. Molecular Cancer Therapeutics. ,vol. 2, pp. 199- 205 ,(2003)
Fang Wang, Stacy Denison, Jin-Ping Lai, Leslie A. Philips, Damien Montoya, Norman Kock, Birgitt Schüle, Christine Klein, Viji Shridhar, Lewis R. Roberts, David I. Smith, Parkin gene alterations in hepatocellular carcinoma Genes, Chromosomes and Cancer. ,vol. 40, pp. 85- 96 ,(2004) , 10.1002/GCC.20020
Hidenao Yamamoto, Jiro Fujimoto, Eizo Okamoto, Jun-ichi Furuyama, Taiki Tamaoki, Tomoko Hashimoto-Tamaoki, Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo. International Journal of Cancer. ,vol. 76, pp. 897- 902 ,(1998) , 10.1002/(SICI)1097-0215(19980610)76:6<897::AID-IJC21>3.0.CO;2-Z
Ralph Mazitschek, Athanassios Giannis, Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases. Current Opinion in Chemical Biology. ,vol. 8, pp. 432- 441 ,(2004) , 10.1016/J.CBPA.2004.06.009
Christa Cerni, Telomeres, telomerase, and myc. An update. Mutation Research-reviews in Mutation Research. ,vol. 462, pp. 31- 47 ,(2000) , 10.1016/S1383-5742(99)00091-5